Home IMGO
35.73
  Price0.03%   +0.010
 
loading

Imago Biosciences (IMGO) Latest News

Nov-30-22 04:05AM Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid LeukemiaGlobeNewswire Inc.
Nov-28-22 10:01AM Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022Benzinga
09:00AM Analyst Ratings for Imago BioSciencesBenzinga
Nov-25-22 09:00AM Pharma Stock Roundup: MRK to Buy IMGO, ABBV's Skyrizi Gets EU Nod for New IndicationZacks Investment Research
Nov-22-22 03:01AM What 5 Analyst Ratings Have To Say About Imago BioSciencesBenzinga
12:53PM Imago (IMGO) Shares Surge 104% on Buyout Offer From MerckZacks Investment Research
Nov-22-22 11:06AM Expert Ratings for Imago BioSciencesBenzinga
07:48AM Amazon To $119? Here Are 5 Other Price Target Changes For TuesdayBenzinga
Nov-22-22 03:49AM Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From YesterdayBenzinga
Nov-21-22 03:05AM U.S. stocks trade mostly lower as Dow struggles to hold onto gains and China COVID-19 fears resurfaceMarketWatch
03:00AM Nasdaq Down More Than 100 Points; Gold Falls 1%Benzinga
Nov-21-22 01:38AM Dow attempts to bounce back as U.S. stocks trade mostly lower and China COVID-19 fears resurfaceMarketWatch
01:36AM Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day SessionBenzinga
Nov-21-22 12:31PM U.S. stocks trade lower, led by drop in Nasdaq, as China COVID-19 fears resurfaceMarketWatch
12:14PM Crude Oil Down Over 5%; Imago BioSciences Shares Spike HigherBenzinga
Nov-21-22 11:27AM Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On MondayBenzinga
11:12AM As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just DoubledThe Motley Fool
Nov-21-22 10:16AM Nasdaq Drops Over 50 Points; Bob Iger Returns To Walt DisneyBenzinga
10:06AM Markets will shift to a 'hope' phase next year, and investors would be wise not to miss it, says Goldman SachsMarketWatch
Nov-21-22 07:26AM Markets will shift to a 'hope' phase next year, and investors would be wise not to miss it, says Goldman SachsMarketWatch
Nov-09-22 04:05AM Imago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business UpdatesGlobeNewswire Inc.
Oct-28-22 10:12AM Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022Benzinga
Sep-06-22 04:05AM Imago BioSciences to Participate in the H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewswire Inc.
Aug-19-22 09:55AM Wall Street Analysts Think Imago BioSciences, Inc. (IMGO) Could Surge 83%: Read This Before Placing a BetZacks Investment Research
Aug-16-22 12:46PM HC Wainwright & Co. Maintains Buy Rating for Imago BioSciences: Here's What You Need To KnowBenzinga
Aug-12-22 04:05AM Imago BioSciences Reports Second Quarter 2022 Financial Results and Provides Recent Business UpdatesGlobeNewswire Inc.
Aug-03-22 04:57AM Imago BioSciences to Participate in the 2022 Wedbush PacGrow Healthcare ConferenceGlobeNewswire Inc.
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Cap:    |  Volume (24h):